Significant reductions in weight and comorbidities are seen 10+ years after surgery
TUESDAY, Oct. 11, 2022 (HealthDay News) — Significant and sustained reductions in weight and comorbidities are seen more than a decade after metabolic and bariatric surgery (MBS) in adolescent patients, according to a study published in the October issue of the Journal of the American College of Surgeons.
Nestor de la Cruz-Muñoz, M.D., from University of Miami Miller School of Medicine, and colleagues examined body weight, comorbidity status, social/physical function status, and long-term complications 10 to 18 years after metabolic and bariatric surgery. The analysis included 96 patients who completed surgery at 21 years of age or younger in a tertiary academic center between 2002 and 2010.
The researchers found that at follow-up (mean, 14.2 years), postoperative (90.6 percent Roux-en-Y gastric bypass [RYGB] and 8.3 percent laparoscopic adjustable gastric banding [LAGB]) mean total body weight decreased by 31.3 percent (32.0 percent for RYGB and 22.5 percent for LAGB). One hundred percent remission was reported among patients with pre-MBS hyperlipidemia (14.6 percent), asthma (10.4 percent), and diabetes/hyperglycemia (5.2 percent). Additionally, pre–post decreases were seen for hypertension, sleep apnea, gastroesophageal reflux disease, anxiety, and depression.
“These findings have important implications for adolescents who may be considering MBS for weight reduction and overall health improvements that extend into adulthood,” the authors write.
Copyright © 2022 HealthDay. All rights reserved.
